Antagonist

Results: 956



#Item
461NAUSEA OR VOMITING STANDING ORDER Initiate immediate supportive care I N C Use standing order on ALL patients with these symptoms

NAUSEA OR VOMITING STANDING ORDER Initiate immediate supportive care I N C Use standing order on ALL patients with these symptoms

Add to Reading List

Source URL: saems.net

Language: English - Date: 2009-01-27 16:20:28
462SAEMS NAUSEA AND VOMITING STANDING ORDER TRAINING MODULE  SAEMS NAUSEA AND VOMITING STANDING ORDER Self-Learning Module

SAEMS NAUSEA AND VOMITING STANDING ORDER TRAINING MODULE SAEMS NAUSEA AND VOMITING STANDING ORDER Self-Learning Module

Add to Reading List

Source URL: saems.net

Language: English - Date: 2010-10-21 17:39:44
463N.C. DMA: Medicaid PDL Review Panel  Recommendations, August 25, 2010

N.C. DMA: Medicaid PDL Review Panel Recommendations, August 25, 2010

Add to Reading List

Source URL: ncdhhs.gov

Language: English - Date: 2011-02-07 13:06:00
464Warner-Lambert Company 170 Tabor Road :. Morris Plains, NJ[removed]3416 Fax: [removed]E-mail: [removed]

Warner-Lambert Company 170 Tabor Road :. Morris Plains, NJ[removed]3416 Fax: [removed]E-mail: [removed]

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-12-07 01:41:14
465HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BYSTOLIC safely and effectively. See full prescribing information for BYSTOLIC. • Sick sinus syndrome (unless a pe

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BYSTOLIC safely and effectively. See full prescribing information for BYSTOLIC. • Sick sinus syndrome (unless a pe

Add to Reading List

Source URL: www.frx.com

Language: English
466PDL Phase I Drug Classes – Preferred drug status revised on January 1st of each year

PDL Phase I Drug Classes – Preferred drug status revised on January 1st of each year

Add to Reading List

Source URL: www.dmas.virginia.gov

Language: English - Date: 2012-05-01 10:40:29
467[removed]528–540$25.00 MOLECULAR PHARMACOLOGY U.S. Government work not protected by U.S. copyright http://dx.doi.org[removed]mol[removed]Mol Pharmacol 84:528–540, October 2013

[removed]528–540$25.00 MOLECULAR PHARMACOLOGY U.S. Government work not protected by U.S. copyright http://dx.doi.org[removed]mol[removed]Mol Pharmacol 84:528–540, October 2013

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
468TDM JOURNAL CLUB  Scary Science: Ondansetron Safety in Pregnancy—Two Opposing Results From the Same Danish Registry

TDM JOURNAL CLUB Scary Science: Ondansetron Safety in Pregnancy—Two Opposing Results From the Same Danish Registry

Add to Reading List

Source URL: www.helpher.org

Language: English - Date: 2014-01-31 08:25:35
469Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats Myle`ne Pouliot1,2, Se´bastien Talbot2, Jacques Se´ne´cal2, Florence

Ocular Application of the Kinin B1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats Myle`ne Pouliot1,2, Se´bastien Talbot2, Jacques Se´ne´cal2, Florence

Add to Reading List

Source URL: www.opto.umontreal.ca

Language: English - Date: 2013-10-01 15:55:29
47012-Lipoxygenase inhibitor 15-Lipoxygenase inhibitor 3-Ketosteroid reductase inhibitor 5-alpha-reductase inhibitor 5-Lipoxygenase inhibitor A-beta-blocker

12-Lipoxygenase inhibitor 15-Lipoxygenase inhibitor 3-Ketosteroid reductase inhibitor 5-alpha-reductase inhibitor 5-Lipoxygenase inhibitor A-beta-blocker

Add to Reading List

Source URL: kanaya.naist.jp

Language: English - Date: 2013-06-25 00:28:44